Benign breast diseases (BBDs) deserve attention because of their high prevalence, their impact on women's quality of life (QoL) and, only for some histologic types, their cancerous potential. Fibrocystic breast disease (FBD), recently called "fibrocystic changes," is the most frequent BBD, diagnosed in 50% of clinically and 90% of histopathologically examined women [1].
Contraception in women with benign breast disease and benign uterine and ovarian conditions / Grandi, G.; Del Savio, M. C.; Facchinetti, F.. - (2024), pp. 146-153. [10.1017/9781108961097.021]
Contraception in women with benign breast disease and benign uterine and ovarian conditions
Grandi G.;Del Savio M. C.;
2024
Abstract
Benign breast diseases (BBDs) deserve attention because of their high prevalence, their impact on women's quality of life (QoL) and, only for some histologic types, their cancerous potential. Fibrocystic breast disease (FBD), recently called "fibrocystic changes," is the most frequent BBD, diagnosed in 50% of clinically and 90% of histopathologically examined women [1].
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
